Andreas Reiter

19.3k citations

278 papers · 8.8k · 2 hit papers · h-index 52

Impact in

Hematology top 0.1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research

Papers in

Rheumatology 141
- Eosinophilic Disorders and Syndromes 135
Hematology 130
- Chronic Myeloid Leukemia Treatments 102
- Acute Myeloid Leukemia Research 39

Co-authors: Nicholas C.P. Cross (98 shared papers)Andreas Hochhaus (71 shared papers)Georgia Metzgeroth (66 shared papers)Andrew Chase (20 shared papers)Jason Gotlib (26 shared papers)Rüdiger Hehlmann (35 shared papers)Amy V. Jones (10 shared papers)Katerina Zoi (9 shared papers)
Journals: Blood (80 papers)Leukemia (25 papers)Annals of Hematology (12 papers)British Journal of Haematology (11 papers)Haematologica (11 papers)
Partner nations: Germany United Kingdom United States

In The Last Decade

Andreas Reiter

258 papers receiving 8.6k citations

Andreas Reiter's Hit Papers

align trajectories log scale

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes 2012 · 457 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 Journal of Allergy and Clinical Immunology
2010 Nature Genetics

Peers

Countries citing papers authored by Andreas Reiter

Since Specialization

Citations

This map shows the geographic impact of Andreas Reiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Reiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Reiter more than expected).

Fields of papers citing papers by Andreas Reiter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Reiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Reiter. The network helps show where Andreas Reiter may publish in the future.

Co-authors

The 25 scholars most cited alongside Andreas Reiter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas Reiter Line = papers co-authored together Andreas Reiter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 278 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders Nature Genetics ·Thomas Ernst, Andrew Chase, Joannah Score, Claire Hidalgo-Curtis, Catherine Bryant, Amy V. Jones, Katherine Waghorn, Katerina Zoi, Fiona M. Ross, Andreas Reiter, Andreas Hochhaus, Hans G. Drexler, Andrew Duncombe, Francisco Cervantes, David Oscier, Jacqueline Boultwood, Francis Grand, Nicholas C.P. Cross Hit paper breakdown →	2010	807
2	Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes Journal of Allergy and Clinical Immunology ·Peter Valent, Amy D. Klion, Hans‐Peter Horny, Florence Roufosse, Jason Gotlib, Peter F. Weller, Andrzej Hellmann, Georgia Metzgeroth, Kristin M. Leiferman, Michel Arock, Joseph H. Butterfield, Wolfgang R. Sperr, Karl Sotlar, Peter Vandenberghe, Torsten Haferlach, Hans‐Uwe Simon, Andreas Reiter, Gerald J. Gleich Hit paper breakdown →	2012	457
3	JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms Nature Genetics ·Amy V. Jones, Andrew Chase, Richard T. Silver, David Oscier, Katerina Zoi, Y. Lynn Wang, Holger Cario, Heike L. Pahl, Andrew Collins, Andreas Reiter, Francis Grand, Nicholas C.P. Cross	2009	274
4	Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms Blood ·Francis Grand, Claire Hidalgo-Curtis, Thomas Ernst, Katerina Zoi, Christine Zoi, Carolann McGuire, Sebastian Kreil, Amy V. Jones, Joannah Score, Georgia Metzgeroth, David Oscier, Andrew G. Hall, Christian Brandts, Hubert Serve, Andreas Reiter, Andrew Chase, Nicholas C.P. Cross	2009	273
5	Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR Leukemia ·Michael Emig, Susanne Saußele, H Wittor, A Weißer, Andreas Reiter, Andreas Willer, Ute Berger, Rüdiger Hehlmann, Nicholas C.P. Cross, Andreas Hochhaus	1999	207
6	EZH2 mutational status predicts poor survival in myelofibrosis Blood ·Paola Guglielmelli, Flavia Biamonte, Joannah Score, Claire Hidalgo-Curtis, Francisco Cervantes, Margherita Maffioli, Tiziana Fanelli, Thomas Ernst, N. W. Winkelman, Amy V. Jones, Katerina Zoi, Andreas Reiter, Andrew Duncombe, Laura Villani, Alberto Bosi, Giovanni Barosi, Nicholas C.P. Cross, Alessandro M. Vannucchi	2011	199
7	DNA Topoisomerase II in Therapy-Related Acute Promyelocytic Leukemia New England Journal of Medicine ·Anita R. Mistry, Carolyn A. Felix, Ryan J. Whitmarsh, Annabel Mason, Andreas Reiter, Bruno Cassinat, Anne Parry, Christoph Walz, Joseph L. Wiemels, Mark R. Segal, Lionel Adès, Ian A. Blair, Neil Osheroff, Andrew Peniket, Mårina Lafage‐Pochitaloff, Nicholas C.P. Cross, Christine Chomienne, Ellen Solomon, Pierre Fenaux, David Grimwade	2005	197
8	The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins Blood ·Asuman Demiroglu, E. Joanna Steer, Carol Heath, Kerry Taylor, Mark Bentley, Steven L. Allen, Prasad Koduru, Judith Brody, G. A. T. Hawson, Robyn Rodwell, Mary-Lou Doody, Fernando Carnicero, Andreas Reiter, John M. Goldman, Junia V. Melo, Nicholas C.P. Cross	2001	152
9	Molecular heterogeneity in complete cytogenetic responders after interferon-α therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission Blood ·Andreas Hochhaus, Andreas Reiter, Anja Reichert Susanne Saußele, Michael Emig, Jaspal Kaeda, Beate Schultheis, Ute Berger, Patricia Shepherd, N. C. Allan, Rüdiger Hehlmann, John M. Goldman, Nicholas C.P. Cross	2000	150
10	Myeloid neoplasms with eosinophilia Blood ·Andreas Reiter, Jason Gotlib	2016	149
11	Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction Blood ·Andreas Hochhaus, Feng Lin, Andreas Reiter, Heyko Skladny, PJ Mason, Frits van Rhee, P Shepherd, NC Allan, Rüdiger Hehlmann, JM Goldman, Nicholas C.P. Cross	1996	138
12	Consistent Fusion of ZNF198 to the Fibroblast Growth Factor Receptor-1 in the t(8;13)(p11;q12) Myeloproliferative Syndrome Blood ·Andreas Reiter, Jastinder Sohal, Shashikant Kulkarni, Andrew Chase, Donald Macdonald, Ricardo C.T. Aguiar, Cristina Gonçalves, Jesús María Hernández‐Rivas, Barbara Jennings, John M. Goldman, Nicholas C.P. Cross	1998	135
13	Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood Blood ·Seisho Takeuchi, CR Bartram, Taku Seriu, Miller Cw, A Tobler, JW Janssen, Andreas Reiter, WD Ludwig, Martin Zimmermann, J Schwaller	1995	129
14	Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis Leukemia ·Mohamad Jawhar, Juliana Schwaab, Susanne Schnittger, Manja Meggendorfer, Markus Pfirrmann, Karl Sotlar, H.‐P. Horny, Georgia Metzgeroth, Sebastian Kluger, Nicole Naumann, Claudia Haferlach, Torsten Haferlach, Peter Valent, W.‐K. Hofmann, Alice Fabarius, Nicholas C.P. Cross, Andreas Reiter	2015	126
15	The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes Blood ·Gerlinde Wernig, Jeffrey R. Gonneville, Brian J. Crowley, Margret S. Rodrigues, Mamatha M. Reddy, Heidi E. Hudon, Christoph Walz, Andreas Reiter, Klaus Podar, Yohan Royer, Stefan N. Constantinescu, Michael H. Tomasson, James D. Griffin, D. Gary Gilliland, Martin Sattler	2008	116
16	Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis Blood ·Nicolaus Kröger, Anita Badbaran, Ernst Holler, J. Hahn, Guido Kobbe, Martin Bornhäuser, Andreas Reiter, Tatjana Zabelina, Axel R. Zander, Boris Fehse	2006	106
17	Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field Expert Review of Hematology ·Peter Valent, Gerald J. Gleich, Andreas Reiter, Florence Roufosse, Peter F. Weller, Andrzej Hellmann, Georgia Metzgeroth, Kristin M. Leiferman, Michel Arock, Karl Sotlar, Joseph H. Butterfield, Sabine Cerny‐Reiterer, Matthias Mayerhofer, Peter Vandenberghe, Torsten Haferlach, Bruce S. Bochner, Jason Gotlib, Hans‐Peter Horny, Hans‐Uwe Simon, Amy D. Klion	2012	102
18	Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event Leukemia ·Mohamad Jawhar, Juliana Schwaab, Susanne Schnittger, Karl Sotlar, H.‐P. Horny, Georgia Metzgeroth, Nadine Müller, Sven Schneider, Nicole Naumann, Christoph Walz, Torsten Haferlach, Peter Valent, W.‐K. Hofmann, Nicholas C.P. Cross, Alice Fabarius, Andreas Reiter	2015	98
19	A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia Blood ·Andreas Hochhaus, Andreas Reiter, Heyko Skladny, JV Melo, C. Sick, Ute Berger, JQ Guo, RB Arlinghaus, R. Hehlmann, JM Goldman, Nicholas C.P. Cross	1996	96
20	Fusion of ETV6 to the Caudal-Related Homeobox Gene CDX2 in Acute Myeloid Leukemia With the t(12;13)(p13;q12) Blood ·Andrew Chase, Andreas Reiter, Linda Burci, Giovanni Cazzaniga, Andrea Biondi, Julie Pickard, Irene Roberts, John M. Goldman, Nicholas C.P. Cross	1999	90

About Andreas Reiter

Andreas Reiter is a scholar working on Rheumatology, Hematology, Genetics, Immunology and Pulmonary and Respiratory Medicine, having authored 278 papers that have together received 8.8k indexed citations. Recurring topics across this work include Eosinophilic Disorders and Syndromes (135 papers), Chronic Myeloid Leukemia Treatments (102 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (94 papers), Mast cells and histamine (60 papers), Acute Myeloid Leukemia Research (39 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (26 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Lymphoma Diagnosis and Treatment (13 papers). The work is most often cited by research in Hematology (4.0k citations), Genetics (3.4k citations), Rheumatology (3.2k citations), Immunology (1.6k citations) and Pathology and Forensic Medicine (802 citations). Andreas Reiter has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Nicholas C.P. Cross, Andreas Hochhaus, Georgia Metzgeroth, Andrew Chase, Jason Gotlib, Rüdiger Hehlmann, Amy V. Jones, Katerina Zoi, Francis Grand and Thomas Ernst. Their work appears in journals such as Blood, Leukemia, Annals of Hematology, British Journal of Haematology and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Andreas Reiter

Impact in

Papers in i

In The Last Decade

Andreas Reiter

Andreas Reiter's Hit Papers

Peers

Countries citing papers authored by Andreas Reiter

Fields of papers citing papers by Andreas Reiter

All Works

About Andreas Reiter

Explore authors with similar magnitude of impact

Papers in